Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Medtronic
Express Scripts
US Department of Justice
Accenture
Queensland Health
Merck
Fish and Richardson
AstraZeneca

Generated: May 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019885

« Back to Dashboard

NDA 019885 describes ACCUPRIL, which is a drug marketed by Pfizer Pharms and is included in one NDA. It is available from three suppliers. Additional details are available on the ACCUPRIL profile page.

The generic ingredient in ACCUPRIL is quinapril hydrochloride. There are eleven drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the quinapril hydrochloride profile page.
Summary for 019885
Tradename:ACCUPRIL
Applicant:Pfizer Pharms
Ingredient:quinapril hydrochloride
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 019885
Suppliers and Packaging for NDA: 019885
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ACCUPRIL quinapril hydrochloride TABLET;ORAL 019885 NDA Parke-Davis Div of Pfizer Inc 0071-0527 N 0071-0527-23
ACCUPRIL quinapril hydrochloride TABLET;ORAL 019885 NDA Parke-Davis Div of Pfizer Inc 0071-0527 N 0071-0527-40

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 5MG BASE
Approval Date:Nov 19, 1991TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 10MG BASE
Approval Date:Nov 19, 1991TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 20MG BASE
Approval Date:Nov 19, 1991TE:ABRLD:Yes

Expired US Patents for NDA 019885

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer Pharms ACCUPRIL quinapril hydrochloride TABLET;ORAL 019885-002 Nov 19, 1991 ➤ Sign Up ➤ Sign Up
Pfizer Pharms ACCUPRIL quinapril hydrochloride TABLET;ORAL 019885-001 Nov 19, 1991 ➤ Sign Up ➤ Sign Up
Pfizer Pharms ACCUPRIL quinapril hydrochloride TABLET;ORAL 019885-001 Nov 19, 1991 ➤ Sign Up ➤ Sign Up
Pfizer Pharms ACCUPRIL quinapril hydrochloride TABLET;ORAL 019885-004 Nov 19, 1991 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Harvard Business School
Cerilliant
Colorcon
Healthtrust
Mallinckrodt
Cipla
Accenture
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.